JUPW News and Press, Jupiter Wellness Inc. From 12/09/21

Jupiter Wellness (NASDAQ:JUPW) has signed an agreement to acquire Next Frontier Pharmaceuticals, through a merger with a subsidiary of Jupiter Wellness. JUPW shares down 8.9% premarket at $1.23. Under the terms of the transaction, Next Frontier Pharma's stockholders will receive sha...

Owner of SYNDROS ® (dronabinol), the only US-based FDA approved CII Tetrahydrocannabinol (THC), a liquid cannabinoid used in adults to treat: Chemotherapy Induced Nausea and Vomiting (CINV) associated in adult patients who have failed to respond adequately to conventional antiemetic tr...

Jupiter Wellness is a clinical-stage pharmaceutical company targeting clinical indications in multi-billion markets with CBD-based medical therapeutics. The Company funds its operations partially through a portfolio of revenue-producing wellness products with or without CBD infusion. ...

JW-300 Demonstrates Efficacy in Treatment of Developing Burns (sunburn) in a Double-Blinded Placebo Controlled Clinical Trial. JUPITER, FL / ACCESSWIRE / November 16, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , a wellness company specializing in the clinical development of skin the...

JUPITER, FL / ACCESSWIRE / November 11, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , a clinical stage company developing cannabinoid receptor agonists for the treatment of eczema, actinic keratosis, burns, and herpes cold sores, announced that it has received an official written response...

Jupiter Wellness (JUPW +2.8%) files a registration statement with the SEC to sponsor Jupiter Wellness Acquisition (JWACU), a SPAC, dedicated to investing in AI based therapeutics and diagnostics with an initial funding target of $100M. Company has finalized the recruitment and on-bo...

AI in medicine is projected to grow 18X from 2018 through 2025 to $35 billion JUPITER, FL / ACCESSWIRE / November 3, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , today announced that it has filed a registration statement with the Securities and Exchange Commission to sponsor Jupiter...

Gainers: Inspira Technologies (NASDAQ:IINN) +54%, SeqLL (NASDAQ:SQL) +46%, Ocugen (NASDAQ:OCGN) +27%, Aziyo Biologics (NASDAQ:AZYO) +15%, Roivant Sciences (NASDAQ:ROIV) +14%. Losers: Evaxion Biotech (NASDAQ:EVAX) -14%, Kiromic BioPharma (...

JUPITER, FL / ACCESSWIRE / October 19, 2021 / Jupiter Wellness , Inc. (NASDAQ:JUPW) , a clinical stage company developing a cannabinoid receptor agonist for the treatment of first degree burns, announced the enrollment and dosing of the first patient in the study. The double-blinded place...

Gainers: Camber Energy (NYSE:CEI) +97%. Merus (NASDAQ:MRUS) +32%. New Fortress Energy (NASDAQ:NFE) +25%. Paltalk (NASDAQ:PALT) +25%. Grom Social Enterprises (NASDAQ:GROM) +20%. DatChat (NASDAQ:DATS) +20%. Jupiter Wellness (NASDAQ:JUPW) +18%. NextPlay Technologies (NASDAQ:NXTP) +19%. Independe...